Intercell AG
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 44 (Table of Contents)
Published: 4 Feb-2004
DOI: 10.3833/pdr.v2004.i44.833 ISSN: 1756-7874
Section: Company Profile
Fulltext:
Abstract
Intercell aims in developing a new generation of chemically defined vaccines for preventing and treating infectious diseases including chronic infections and cancer...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS